Total Payments
$373,619
2024 Payments
$17,200
Companies
77
Transactions
2,568
Medicare Patients
4,097
Medicare Billing
$902,712
Payment Breakdown by Category
Other$266,793 (71.4%)
Food & Beverage$56,338 (15.1%)
Consulting$35,086 (9.4%)
Travel$14,319 (3.8%)
Education$1,084 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $266,793 | 184 | 71.4% |
| Food and Beverage | $56,338 | 2,253 | 15.1% |
| Consulting Fee | $35,086 | 18 | 9.4% |
| Travel and Lodging | $14,319 | 85 | 3.8% |
| Education | $1,084 | 28 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $106,248 | 223 | $0 (2024) |
| GENZYME CORPORATION | $81,432 | 189 | $0 (2024) |
| ABBVIE INC. | $35,693 | 205 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $22,908 | 32 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $20,234 | 212 | $0 (2024) |
| EMD Serono, Inc. | $19,079 | 104 | $0 (2024) |
| Genentech USA, Inc. | $18,966 | 122 | $0 (2024) |
| Allergan, Inc. | $17,722 | 210 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $15,079 | 22 | $0 (2022) |
| LivaNova USA, Inc. | $4,501 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,200 | 312 | ABBVIE INC. ($6,441) |
| 2023 | $24,298 | 308 | AbbVie Inc. ($8,867) |
| 2022 | $74,082 | 345 | Biogen, Inc. ($21,971) |
| 2021 | $58,827 | 363 | Biohaven Pharmaceuticals, Inc. ($22,908) |
| 2020 | $29,811 | 304 | Allergan, Inc. ($14,007) |
| 2019 | $52,122 | 301 | Biogen, Inc. ($19,994) |
| 2018 | $52,453 | 291 | GENZYME CORPORATION ($27,351) |
| 2017 | $64,826 | 344 | Biogen, Inc. ($23,992) |
All Payment Transactions
2,568 individual payment records from CMS Open Payments — Page 1 of 103
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Neurology | ||||||
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Central Nervous System | ||||||
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: PAIN | ||||||
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/16/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $1.09 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Neurology | ||||||
| 12/10/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $1.87 | General |
| Category: Neurology | ||||||
| 12/09/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Neurology | ||||||
| 12/06/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Travel and Lodging | In-kind items and services | $77.72 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $38.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Travel and Lodging | In-kind items and services | $1.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/03/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.30 | General |
| Category: Neuroscience | ||||||
| 12/02/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $50.07 | General |
| Category: AMANTADINE | ||||||
| 12/01/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Neurology | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,077 | 32,574 | $753,090 | $301,423 |
| 2022 | 17 | 1,018 | 26,182 | $580,675 | $233,053 |
| 2021 | 16 | 1,068 | 17,920 | $469,283 | $199,354 |
| 2020 | 13 | 934 | 15,045 | $390,270 | $168,883 |
Total Patients
4,097
Total Services
91,721
Medicare Billing
$902,712
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 39 | 22,195 | $221,950 | $102,725 | 46.3% |
| J1306 | Injection, inclisiran, 1 mg | Office | 2023 | 15 | 8,804 | $176,080 | $82,593 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 244 | 390 | $72,150 | $33,367 | 46.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 179 | 259 | $33,670 | $14,805 | 44.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 99 | 99 | $30,690 | $11,438 | 37.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 91 | 96 | $24,000 | $9,052 | 37.7% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 35 | 36 | $16,200 | $7,273 | 44.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 23 | 55 | $33,000 | $6,350 | 19.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 39 | 41 | $12,300 | $5,183 | 42.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 34 | 64 | $22,400 | $4,712 | 21.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 13 | 13 | $7,150 | $4,120 | 57.6% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 44 | 85 | $21,250 | $3,906 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 41 | 43 | $7,955 | $2,998 | 37.7% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 17 | 72 | $14,200 | $2,902 | 20.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 63 | 69 | $37,950 | $2,860 | 7.5% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 17 | 36 | $7,400 | $2,690 | 36.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 39 | $6,825 | $2,308 | 33.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,775 | $1,173 | 42.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 90 | $4,050 | $890.32 | 22.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 73 | $1,095 | $78.81 | 7.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 39 | 24,766 | $228,280 | $116,847 | 51.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 309 | $55,895 | $26,865 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 165 | 231 | $29,000 | $13,232 | 45.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 91 | 95 | $23,750 | $9,091 | 38.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 62 | 63 | $18,900 | $8,503 | 45.0% |
About Dr. Bruce Cotugno, M.D
Dr. Bruce Cotugno, M.D is a Neurology healthcare provider based in Washington, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1972580983.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Cotugno, M.D has received a total of $373,619 in payments from pharmaceutical and medical device companies, with $17,200 received in 2024. These payments were reported across 2,568 transactions from 77 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($266,793).
As a Medicare-enrolled provider, Cotugno has provided services to 4,097 Medicare beneficiaries, totaling 91,721 services with total Medicare billing of $902,712. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Washington, PA
- Active Since 12/30/2005
- Last Updated 03/16/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1972580983
Products in Payments
- AUBAGIO (Drug) $51,997
- UBRELVY (Drug) $38,671
- TYSABRI (Biological) $38,288
- NURTEC ODT (Drug) $38,250
- TECFIDERA (Drug) $30,720
- OCREVUS (Biological) $20,086
- GILENYA (Drug) $18,218
- VUMERITY (Drug) $12,525
- QULIPTA (Drug) $10,970
- DISEASE STATE (Drug) $9,671
- Mavenclad (Drug) $7,671
- MAVENCLAD (Drug) $6,889
- VNS Therapy (Device) $4,453
- ZINBRYTA (Biological) $4,414
- BOTOX (Biological) $2,652
- NUPLAZID (Drug) $1,220
- Briviact (Drug) $1,172
- KESIMPTA (Drug) $1,085
- AUSTEDO (Drug) $1,074
- INBRIJA (Drug) $1,032
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Washington
Dr. Laxman Bahroo, D.o,, D.O,
Neurology — Payments: $3.4M
Neurology $3.4M
Dr. Fahd Amjad, Md, MD
Neurology — Payments: $2.4M
Neurology $2.4M
Jessica Ailani, Md, MD
Neurology — Payments: $1.3M
Neurology $1.3M
Fernando Pagan
Neurology — Payments: $1.1M
Neurology $1.1M
Dr. Yasar Torres-Yaghi, M.d, M.D
Neurology — Payments: $868,293
Neurology $868,293
Benjamin Osborne
Neurology — Payments: $770,154
Neurology $770,154